Demand For Ceftriaxone Sodium (API) Market To Be Fueled By Changes In Consumer Perception And Growing Awareness : Fact.MR

Ceftriaxone Sodium (API) Market is an active pharmaceutical ingredient that is used as an antibiotic to treat a variety of bacterial infections, including urinary tract infections, meningitis, pneumonia, gonorrhea, bone and joint infections, skin infections, and pelvic inflammatory disease. Third-generation cephalosporin Ceftriaxone Sodium (API) is sometimes used in preventive medications following surgery to prevent infection.

In the world market for ceftriaxone sodium (API), China and India are significant markets. Both countries have been severely impacted by the COVID-19 pandemic, which has affected the workforce and manufacturing facilities that produce ceftriaxone sodium. (API). The global ceftriaxone sodium (API) market will be impacted by indirect issues such as congested logistics and frequent unpredictable lockdowns in addition to these direct issues.

Download Free Sample Copy of this Report –

Ceftriaxone Sodium (API) Market: Segmentation

The international ceftriaxone sodium (API) treatment market is segmented based on product type, application type, distribution channel and region.

By product type, the global ceftriaxone sodium (API) market is segmented as:

  • > 99.5
  • > 99.8

By application type, the global ceftriaxone sodium (API) market is segmented as:

  • Powder Injection
  • Injection

By distribution channel, the global ceftriaxone sodium (API) market is segmented as:

  • Direct Sales
  • Through Distributor
Ceftriaxone Sodium (API) Market: Drivers and Restraints

The major driver for the global market for ceftriaxone sodium (API) is rising prevalence of infectious diseases globally. Another major driver for the growth of API market in general would be expiration of patentability of blockbuster drugs in the coming few years which will make manufacturing of their generic versions possible for the generic manufacturers.

The big pharma giants outsource the manufacturing process after these expirations which help them to continue keeping focus on their core competencies of drug development. Such collaborations are expected to push the ceftriaxone sodium (API) market forward for growth. Changing lifestyles and life choices like smoking are making people more susceptible to infections which in turn would be a driver for the growth of the global market for ceftriaxone sodium (API).

Additionally, there is growing prevalence of hospital acquired infections worldwide which would again be a driver for the growth of international market of ceftriaxone sodium (API). Increasing number of surgeries in general are expected to make people more prone to infections which in turn can be expected to drive the global market of ceftriaxone sodium (API).

Ceftriaxone Sodium (API) Market: Key Players

The key players for the global ceftriaxone sodium (API) market are

  • Shandong Luoxin Pharmaceutical Group Stock Co
  • Livzon Pharmaceutical
  • United Laboratories
  • Sinopharm Sandwich
  • Shanghai Pharmaceutical
  • North China Pharmaceutical Co.
  • China Union Chempharma
  • Lupin Pharmaceuticals
  • Fujian Fukang Pharmaceutical
  • Qilu Antibiotics Pharmaceutical
  • Youcare Pharmaceutical Group Co Ltd.
  • Hospira among others.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583